{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02247",
      "entity_text" : "EVOO",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The major clinical implication of our study is that EVOO may decrease the inflammation biomarkers in HIV infected persons (such as hsCRP) during the 3-week period in compliant participants.",
  "reading_complete" : "2020-08-04T14:08:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:06:03Z",
  "trigger" : "decrease",
  "evidence" : [ "EVOO may decrease the inflammation" ],
  "pmc_id" : "4544351",
  "score" : 0
}